The best value GLP-1 for mothers, total cost first.

One flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.

Semaglutide:

$99/mo

Tirzepatide:

$149/mo

States:

All 50 states

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

Semaglutide:

$69/mo (was $299)

Tirzepatide:

$119/mo (was $399)

States:

Not published

The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.

Semaglutide:

$79/mo

Tirzepatide:

$129/mo

States:

All 50 states

A low-entry, all-in compounded program with both molecules and a clean cancel-anytime policy — appealing if the starting price holds, but the ongoing rate isn't published and the outcome claims are unverified marketing.

Semaglutide:

From $99/mo

Tirzepatide:

From $169/mo

States:

US (availability varies by state)

Four flat, posted price points across semaglutide and three tirzepatide formats, with a written promise the cost won't climb with your dose — a real step up in clarity from what we found last check — undercut by a state list it still won't publish.

Semaglutide:

$99/mo (flat)

Tirzepatide:

$139/mo for the weekly injection, flat at every dose ($129/mo sublingual, $116/mo microdosed)

States:

US (state list not published)

The cheapest headline numbers in this batch — $99/mo semaglutide, $183/mo tirzepatide, each a 10-week protocol — from a named physician who personally reviews every intake, inside a much broader peptide-and-longevity menu where GLP-1 is two SKUs among many.

Semaglutide:

$99/mo

Tirzepatide:

$183/mo

States:

All 50 states

Compounded semaglutide from $129 a month and tirzepatide from $199, held at the same price at every dose, plus a separate microdose line from $109 for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prices are published as starting points rather than a single rate, and the first-order discount of up to $140 is promotional.

Semaglutide:

From $129/mo (floor)

Tirzepatide:

From $199/mo (floor)

States:

All 50 states plus Washington D.C.

Starting at $147/mo semaglutide or $249/mo tirzepatide, in your choice of injection or an oral dissolving tablet at the same price, with the widest state coverage in this batch (49 states) — but no cancellation policy is published anywhere.

Semaglutide:

$147/mo

Tirzepatide:

$249/mo

States:

49 states — excludes only Louisiana

Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.

Semaglutide:

$149/mo (injectable) · $99/mo (oral lozenge)

Tirzepatide:

$325/mo standard ($199/mo on auto-refill)

States:

Multi-state (state list not published)

Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with the strictest cancellation policy in this batch and a live FDA-approved/compounded contradiction on its own glp1-b12 page.

Semaglutide:

$149/mo

Tirzepatide:

$249/mo

States:

Most states — not available in Alabama or Idaho; its GLP-1/B12 combo also excludes Alaska and Hawaii

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

Semaglutide:

$175/mo

Tirzepatide:

$235/mo

States:

All 50 states

Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to $139 and $159 only if you buy a year up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget I couldn't verify because Trustpilot blocks automated checks.

Semaglutide:

$179/mo

Tirzepatide:

$209/mo

States:

All 50 states (as advertised)

Four named pharmacies, a named prescribing partner and brand-name Wegovy, Zepbound and Ozempic alongside the compounded line — that is a fuller disclosure than most of this roster manages. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249, and the price attaches to the form rather than the molecule: the product page never says whether you are getting semaglutide or tirzepatide, and the terms confirm both are in scope. Two things deserve a mother's attention before she enrolls. The brand products are priced as a membership plus an undisclosed medication cost, and that membership is quoted at two different figures on one page, $99 beside Zepbound and Wegovy and $171 beside Ozempic. And the terms state that if a provider decides a different molecule suits you better, staying enrolled is itself your consent to the switch and the charges continue. It also discloses, unusually plainly, that people shown in its advertising may be actors or artificial intelligence rather than clinicians.

Semaglutide:

From $179/mo (floor)

Tirzepatide:

From $179/mo (floor)

States:

All 50 states and DC, qualified in its own terms

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

Semaglutide:

$199/mo

Tirzepatide:

Offered (price not published on-site)

States:

All 50 states (as advertised)

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

All 50 states (not Puerto Rico)

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

Semaglutide:

$199-299/mo depending on form

Tirzepatide:

$349-399/mo depending on form

States:

All 50 states (as advertised)

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

Semaglutide:

$199/mo month-to-month ($185/mo on the 12-month plan)

Tirzepatide:

$299/mo month-to-month ($293/mo on the 12-month plan)

States:

All 50 states + Puerto Rico (as advertised)

Pallas Health carries both routes at once — compounded semaglutide at roughly $199 a month and tirzepatide at $299, alongside genuine FDA-approved Zepbound at $1,069, Ozempic at $1,299 and Wegovy and Mounjaro at $1,349, all cash-pay on one platform. The price is flat at every dose, answered directly in its own FAQ, and the clinician, dose adjustments, check-ins and messaging are inside that figure with no membership fee layered on. Two clinicians are named and both verify as active in the federal NPI registry, the LegitScript seal is genuine rather than a self-hosted image, and there is a real refund policy — full refund if a clinician declines you, a $5 processing fee on a qualifying cancellation. Two caveats matter for a household budget: billing lands every 12 weeks in $597 and $897 blocks rather than monthly, so the advertised per-month figures are Pallas's own averages, and the compounding pharmacy is never named. There is also no postpartum, breastfeeding or PCOS content on the site at all.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

All 50 states + D.C. (async in 43)

Semaglutide is $199 a month either as the weekly shot or a daily pill, tirzepatide is $299 bundled with B12 and glycine, and every plan includes a body-composition scale that tracks whether you are losing fat or muscle — a genuinely different question from what the bathroom scale answers. Two things to read closely: no price appears anywhere on the public site until you have handed over your height, weight and date of birth, and the money-back promise on the homepage is not the one written into the terms.

Semaglutide:

$199/mo, injection or oral

Tirzepatide:

$299/mo, bundled with B12 and glycine

States:

46 states and Washington, D.C. — not Alabama, Arkansas, Louisiana or Mississippi

Semaglutide runs $199/mo month-to-month and tirzepatide $299, falling to $99 and $159 only if you prepay a full year — and the platform names its pharmacies, its clinical group and its chief medical officer, which most of this roster does not. The catch is the middle of the ladder: the 6-month rates are introductory and renew higher, and there is no postpartum or PCOS content anywhere on the site.

Semaglutide:

$199/mo month-to-month, $99/mo on the 12-month plan

Tirzepatide:

$299/mo month-to-month, $159/mo on the 12-month plan

States:

49 states — everywhere except Louisiana

A flat $199/mo semaglutide and $299/mo tirzepatide, with a real non-injection option most of this batch skips: sublingual tablets for both molecules — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not disclosed on the public site we reviewed

Cheap compounded injections with free coaching and no membership — a fair budget pick if you read past the multi-month 'from $119' headline and accept unnamed pharmacies and a no-refund-after-shipping policy.

Semaglutide:

$235/mo

Tirzepatide:

$285/mo

States:

~45 states (as reported; list not published)

One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.

Semaglutide:

$249/mo with no commitment ($212/mo on the 12-month plan)

Tirzepatide:

$329/mo with no commitment ($280/mo on the 12-month plan)

States:

40 states + DC (not AL, AR, GA, HI, LA, MS, MO, ND, SC, TN)

Injection or sublingual, both molecules — but we list it only with full disclosure: a 2025 FDA warning letter and a BBB complaint pattern around surprise 3-month charges make cancellation the real risk here.

Semaglutide:

$249/mo

Tirzepatide:

$299/mo

States:

Most states (not MS, LA, CA)

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

Semaglutide:

$249/mo

Tirzepatide:

$329/mo

States:

All 50 states (as advertised)

Try Ageless publishes its full pricing table before any intake — a real transparency advantage — and then leads with a figure that is not a monthly price. Month to month, compounded semaglutide is $279 and tirzepatide is $349, flat at every dose, with B12 and all injection supplies included; the '$199/mo' on the product card is the yearly plan, $2,388 charged up front. Tirzepatide is also sold as daily sublingual drops at $199 a month for patients who will not inject. Unusually for this category it names both its prescribing practice (Wasef Health, PC, with Michael Wasef, MD — NPI 1417261926, internal medicine, active in NPPES) and its compounding pharmacy (The Pharmacy Hub LLC, NPI 1316684616, active), and both verify independently in the federal registry. Against that, the terms of use publish no refund policy, no cancellation policy and no auto-renew disclosure despite marketing 'cancel anytime', no state list is published anywhere, and there is no postpartum, breastfeeding or PCOS guidance on the site at all — a real gap for the readers this site is written for.

Semaglutide:

$279/mo

Tirzepatide:

$349/mo

States:

No published state list

The most complete set of routes on this roster — a real branded lane through insurance or LillyDirect, a compounded lane that charges the same for tirzepatide as for semaglutide, and a non-GLP-1 generics lane — undercut by a three-day refund window and a complaint pattern that sits squarely on billing.

Semaglutide:

$299/mo

Tirzepatide:

$299/mo

States:

Not disclosed — no published state list

Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.

Semaglutide:

From $299/mo

Tirzepatide:

From $399/mo

States:

36 states

Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.

Semaglutide:

$299/mo

Tirzepatide:

$349/mo

States:

44 states (not AL, AR, CA, LA, MS, ND)

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

Semaglutide:

$79/mo, same price at every dose

Tirzepatide:

$119/mo, same price at every dose

States:

All 50 states

Lean Meds sells one all-inclusive membership per molecule — the telehealth visit, the care plan, the medication and shipping in a single monthly charge, at the same price whatever dose you end up on — and it publishes the whole price ladder on the homepage before you answer a single question. That is the good part, and the flat-by-dose promise matters more than the sticker: providers that charge by dose routinely double between a starting dose and a maintenance dose, and this one does not. The sticker itself needs reading carefully, because the $69 the homepage headlines under a countdown timer is the twelve-month tier; month to month it is $79 for compounded semaglutide and $109 for compounded tirzepatide, with $76/$105 at three months and $73/$100 at six. Two things temper it. The clinical and pharmacy layers are thin on names — clinicians come from the OpenLoop network, fills go to unnamed 503A pharmacies 'within the Lean Meds pharmacy network,' and no individual pharmacy or clinician appears anywhere. And the operator named throughout its own Terms, Trinity HealthCare Supply, LLC, is the company FDA wrote to on 8 June 2026 under its other brand, altRx, for putting its own name on vials it did not compound and calling compounded GLP-1s 'clinically proven.' That letter is about altrx.com, not this site — but it is the same legal entity at the same Miami suite, and a search for 'Lean Meds' alone would never surface it.

Semaglutide:

$79/mo month-to-month ($69/mo on the 12-month plan)

Tirzepatide:

$109/mo month-to-month ($95/mo on the 12-month plan)

States:

All 50 states

A Texas-only practice that owns its own compounding pharmacy — real vertical accountability — with an aggressive $79 first-month semaglutide price, but the site never says what you pay in month two, and 49 states plus DC can't use it at all.

Semaglutide:

$79/mo (first month)

Tirzepatide:

$119/mo

States:

Texas only

A rare needle-free option at true price parity — $79/mo semaglutide or $133/mo tirzepatide, injectable or oral, same price — though NuuVim frames it as a new-patient rate with an unpublished refill tier, and its 50-state coverage claim couldn't be confirmed on its own live site this pass.

Semaglutide:

$79/mo | New GLP-1 Users

Tirzepatide:

$133/mo | New GLP-1 Users

States:

Not verified by observation

An outlier-low, locked-rate flat price — $83/mo for tirzepatide, $250/mo for semaglutide — stated with no promotional hedge, though notably below every comparable compounded-tirzepatide price elsewhere among the providers we track and worth confirming carefully before signing up.

Semaglutide:

$250/mo

Tirzepatide:

$83/mo

States:

Not disclosed — no published state list

Eighty-six dollars a month for compounded semaglutide is among the lowest figures on this page, and $125 for tirzepatide is genuinely cheap for the dual agonist. What sits directly beneath those numbers is the problem. Each card carries an average: "Average 15-20% body weight loss" on the semaglutide, "Average 20-25%" on the tirzepatide. The upper end of that second range is higher than tirzepatide achieved at its maximum dose in its own registrational trial, and these are compounded products that were never in one.

Semaglutide:

From $86/mo

Tirzepatide:

From $125/mo

States:

Not published on the site

This clinic sells milligrams, not months, and it is honest enough to show you the sum. Sixty milligrams of tirzepatide costs $399.99 and lasts twelve weeks — at 2.5, then 5, then 7.5 mg a week, which is exactly sixty. Stay on the ladder and that is about $145 a month. Reach a maintenance dose of 10 mg and the same vial is gone in six weeks; at the 15 mg ceiling, four. The mechanism is published. The headline is the number that only holds at the bottom.

Semaglutide:

$87/mo at the starting dose; about $250 at maintenance

Tirzepatide:

$145/mo at the starting dose; about $435 at the ceiling

States:

A Utah practice, in clinic and by telehealth

LegitScript-certified and licensed in all 50 states, with GLP-1 treatments starting at $89/month (all-inclusive: consult, medication, clinical support, free shipping) — but the homepage hero banner separately advertises '$99 first month' for the same program, an unresolved on-site inconsistency, and tirzepatide is offered in the nav with no price disclosed anywhere. Maves operates under parent brand Homera Health, disclosed via its own footer and login links rather than hidden, and the site charges no separate membership fee on top of the treatment price — but it also publishes no cancellation or refund policy anywhere a reader can check before paying, which is a real gap for a program billed monthly.

Semaglutide:

$89/mo

Tirzepatide:

Not disclosed separately

States:

Nationwide — licensed in all 50 states (excludes U.S. territories), per site copy

A LegitScript-certified compounded GLP-1 platform advertising $89/mo semaglutide and $139/mo tirzepatide — but those are first-month-only promos, the real month-two price is never published, and nothing addresses PCOS, postpartum, or breastfeeding.

Semaglutide:

$89/mo first month (promo)

Tirzepatide:

$139/mo first month (promo)

States:

Not disclosed — no published state list

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

Semaglutide:

$99/mo

Tirzepatide:

$199/mo

States:

36 states

Compounded semaglutide from $99 a month and tirzepatide from $149, with no membership fee, a dietitian attached to every plan, and a genuinely deep FAQ library that has a whole section on pregnancy — rarer here than it should be. Read two promises carefully before you sign. Every page says 'No price increases — ever', while the billing consent you actually click to accept reserves Harbor's right to change pricing on thirty days' notice. And 'No results? No charge' is a twelve-month guarantee with eight conditions attached, including staying enrolled for all twelve months and taking no other weight-loss medication in the year before you start. Every price on the site is a floor, so what you pay after the first month is not published anywhere.

Semaglutide:

From $99/mo — a floor; no ongoing rate is published

Tirzepatide:

From $149/mo — a floor; no ongoing rate is published

States:

Does not publish a service area

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in, and there's no postpartum or PCOS-specific content.

Semaglutide:

From $99/mo

Tirzepatide:

From $140/mo

States:

All 50 states

Shapely is the first provider in this batch that takes insurance — it says it is in network with Medicare and major PPO plans, and quotes brand-name co-pays of "typically $25 per month". That genuinely changes the arithmetic for anyone with coverage. What has to be read carefully is what the membership buys: $99 a month, $49 for the first, and it explicitly does not include medications or labs. So the compounded prices, $99 for semaglutide and $166 for tirzepatide, sit on top of the membership rather than replacing it.

Semaglutide:

$99/mo cash-pay, on top of the membership

Tirzepatide:

$166/mo cash-pay, on top of the membership

States:

Not published on the site

One of the lowest disclosed GLP-1 starting prices in this round — from $99/mo semaglutide, $133/mo tirzepatide — with an explicit no-membership, no-hidden-fee claim, and no postpartum or PCOS-specific content.

Semaglutide:

Starting at $99/mo

Tirzepatide:

Starting at $133/mo

States:

All 50 states

A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, both prices are 'From' starting prices, and no content addresses postpartum or PCOS.

Semaglutide:

From $99/mo

Tirzepatide:

From $183/mo

States:

All 50 states

One of the cheapest flat rates on this list — $99/mo for either molecule, inclusive of consult and shipping by its own FAQ — but clinical review runs through a third-party 'Lion MD' network it shares with at least one other seller, and it doesn't publish a state list.

Semaglutide:

$99/mo

Tirzepatide:

$99/mo

States:

Does not disclose a specific state list

Compounded semaglutide at $99 and tirzepatide at $149, and unusually for this roster the renewal price is identical to the advertised one, so the promise that the rate will not rise is actually borne out in the checkout data. The number to read carefully is the cycle: a plan month is four weeks, and the '12-month plan' at $999 buys 48 weeks rather than a year. The larger caveat is corporate. Trinity Meds is operated by the same company as Lean Meds, altRx and NextMeds, so listing them would present one business as four independent choices, and that operator holds an open FDA warning letter.

Semaglutide:

$99 per 4 weeks

Tirzepatide:

$149 per 4 weeks

States:

All 50 states

Livea is one of the few names here with a history that predates the GLP-1 boom — it operates as Livea Medical, PLLC under Minnesota Weight Control, Inc., a weight-management business rather than a telehealth startup. Compounded semaglutide starts at $99 a month and tirzepatide at $199 "when available", a qualification most sellers leave out. It also does something unusual in its own FAQ: it puts its price next to the brand-name alternative, "compared to $1,000+ per month for brand-name Ozempic or Wegovy".

Semaglutide:

From $99/mo

Tirzepatide:

From $199/mo, when available

States:

Not published; a Minnesota company offering virtual care

One of the network's longer-established telehealth operators (since 2008) — as low as $99/mo semaglutide, $269/mo tirzepatide — though state coverage isn't itemized and no content addresses postpartum or PCOS. Its menu extends well beyond GLP-1s into ED treatment, testosterone, hormone optimization, and hair regrowth, all on the same account.

Semaglutide:

As low as $99/mo

Tirzepatide:

As low as $269/mo

States:

Not disclosed — no published state list (marketing describes the service broadly, without itemizing states)

One of the few genuinely flat prices on this list — $99/mo semaglutide and $134/mo tirzepatide that do not rise as your dose does, in all fifty states — from a company that never names itself anywhere on its own website.

Semaglutide:

$99/mo

Tirzepatide:

$134/mo

States:

All 50 states

One of only two sellers in this group that publishes the states it actually serves, and the only one that also runs in-person clinics rather than working entirely by mail. Twenty-six states are listed by name, which is a stronger claim than the all-fifty assertion most of this list makes. Semaglutide with B12 starts at $99 a month and tirzepatide with B12 at $179, on monthly or quarterly plans, and both numbers are floors rather than rates: the per-dose ladder appears only after the intake has asked for a name and an email, so the price at a maintenance dose is the one thing the public pages do not give you. Labs are billed on top at $89 for the essential panel or $189 for the comprehensive one, disclosed in the FAQ rather than beside the price. The operating company, Magnolia Regenerative Medicine Health, LLC, is named with a phone number. The terms are strict on the way out: no refunds on medications at all, and cancellation requires written notice at least 24 hours before the monthly renewal.

Semaglutide:

From $99/mo (floor)

Tirzepatide:

From $179/mo (floor)

States:

26 states, enumerated

A three-molecule menu — semaglutide, tirzepatide, and the less commonly offered liraglutide (a compounded, $150/mo third option distinct from either tracked drug) — starting at $99/mo, with 'all doses included' pricing and HSA/FSA accepted, from a St. Petersburg, FL multi-vertical telehealth practice with a named address (Address: St Petersburg, FL) and phone number (305-930-8817) rather than an anonymous storefront, plus a rotating 'save $75 on your first order' promo that runs alongside the standing rate.

Semaglutide:

$99/mo

Tirzepatide:

$149/mo

States:

Not publicly disclosed

One-time 30-day kits — as low as $99 for a single-dose-vial option, or $125-145 for the larger HomeKit — with a full refund if the reviewing physician doesn't approve you, but GLP-1 is just one line in a broad injectables catalog with no state list or pregnancy/breastfeeding guidance.

Semaglutide:

$99/mo

Tirzepatide:

$99/mo

States:

Not disclosed — no published state list

⛔ FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront. The site also publishes its own named competitor-comparison pricing chart, claiming access to '1000+ physicians' across all 50 states and a signup-to-treatment window of as little as 4 days.

Semaglutide:

$99.97/mo

Tirzepatide:

$144.49/mo

States:

All 50 states

A flat $99.99/mo semaglutide, $144.97/mo tirzepatide compounded option bundling the visit, medication, and shipping into one price — offset by a disclosed 3-month minimum commitment. A separate $149/$249 first-month rate applies only to upfront payment, and the site states plainly that dosage does not change the price.

Semaglutide:

$99.99/mo

Tirzepatide:

$144.97/mo

States:

Not disclosed — no published state list

A flat ~$100/mo ('$25/week') program covering either semaglutide or tirzepatide, with dietitian support and clinician check-ins bundled in, and a named 503B pharmacy partner — genuinely more pharmacy transparency than most peers. It doesn't publish which states it serves.

Semaglutide:

$100/mo flat

Tirzepatide:

$100/mo flat

States:

Not disclosed

Two clean numbers on the weight-loss page — semaglutide with B-6 from $109 a month, tirzepatide with B-6 from $159 — and one trap sitting right beside them. The third card, Bio-Boost Plus at $129, is a lipotropic fat-metabolism injection, not a GLP-1, and it sits between the two that are. Vita Bella sells a very large catalog beyond weight loss, so the product label matters more here than usual. Worth knowing before you sign up: provider check-ins are quarterly, not monthly.

Semaglutide:

From $109/mo with B-6

Tirzepatide:

From $159/mo with B-6

States:

Not published on the site

Both prices on this site are promotional, and SurpassMD says so itself — buried in the FAQ rather than beside the numbers: "Semaglutide starts as low as $114/m and tirzepatide starts as low as $177/m for eligible patients with a promotion." What it never publishes is the price without one. The rest is unusually well covered: all fifty states plus DC, a 503A pharmacy, cold-chain shipping inside 48 hours, cancel anytime, and an oral semaglutide option — priced nowhere.

Semaglutide:

As low as $114/mo, promotional

Tirzepatide:

As low as $177/mo, promotional

States:

All 50 states and DC

Its pricing table is headed "Transparent Monthly Pricing" and, to anything that does not run JavaScript, it reads $0.00. The figures are count-up animations. Fetch the page the way a search engine does and the semaglutide program costs nothing and the tirzepatide program costs $195.82 — a number that is not what the page shows a human either, which sees $114.99 and $191.99.

Semaglutide:

$114.99/mo

Tirzepatide:

$191.99/mo

States:

Not published

Mondae is the rare provider on this page that will tell you who compounds your medication, and then let you choose. Its configurator names six pharmacies — Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx — and you pick one before checkout, which is a level of supply-chain disclosure most of this category treats as a trade secret. The pricing is straightforward in the way that matters: $115 a month for compounded semaglutide and $145 for compounded tirzepatide, no membership fee on top, and fixed as you titrate, so the number you start at is the number you keep. That last point is worth more than the sticker, because dose-priced plans routinely double between a starting dose and a maintenance dose. Both figures were checked properly rather than copied: the treatment pages are a live configurator that ships a '$NNN' placeholder where the price belongs until the page's scripts run, then cross-checked against the homepage card and the structured data the page publishes — three sources, one number. The gaps are the ordinary ones. Clinicians come through a contracted network, Bask Telehealth LLC, and none is named individually; there are no labs in the plan; nothing on the site speaks to postpartum, breastfeeding or PCOS; and Mondae warns that formulations differ between its six pharmacies and 'may contain additional additives,' which is a fair question to put to whichever one you pick.

Semaglutide:

$115/mo (flat at every dose)

Tirzepatide:

$145/mo (flat at every dose)

States:

All 50 states

⛔ FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though no content addresses postpartum or PCOS. It also runs a member community on Skool, with dietitian-led nutrition guidance folded into that access rather than billed separately.

Semaglutide:

As low as $116/mo

Tirzepatide:

As low as $199/mo

States:

Not disclosed — no published state list

No membership fee — semaglutide starts at $117.96/mo, tirzepatide at $178.98/mo — but Trava's own pages currently disagree with each other on its clinical-partner name and its cheapest semaglutide price, and nothing addresses pregnancy or PCOS.

Semaglutide:

$117.96/mo starting

Tirzepatide:

$178.98/mo starting

States:

All 50 states

Flat-rate pricing with a real dietitian included ($119/mo semaglutide, from $175/mo tirzepatide) from a nine-year-old operator — carrying an open FDA warning letter over how it described its own compounded products.

Semaglutide:

$119/mo flat, all doses

Tirzepatide:

From $175/mo

States:

All 50 states

"As low as $83/mo, all-in" is $999 paid up front, divided by twelve. That is not an inference — the site's own code takes the cheapest tier's total, divides by its month count, and prints the smallest result it finds, and its price API returns $999 for the twelve-month semaglutide supply. Month to month is $119. The honest thing to say next is that $119 is still cheaper than most of this roster, so the problem is the advertised number rather than the price behind it.

Semaglutide:

$119/mo month to month

Tirzepatide:

$139/mo month to month

States:

Not published; U.S. only, and the patient must be in the state they ship to

Compounded semaglutide starting at $119/mo — one of the lower headline prices in this batch — from a multi-category telehealth brand that also runs a dedicated Women's Health line, though tirzepatide is no longer part of its catalog and no state list is published. It claims FDA-regulated pharmacy fulfillment, no membership requirement, and 100,000+ patients served, none of which we could independently verify beyond the site's own copy, and shipping is described as free and discreet at every order. Support is reachable by phone or email seven days a week, per its own posted hours (weekdays 7am-10pm EST, weekends 8am-5pm EST).

Semaglutide:

$119/mo

Tirzepatide:

Not offered — dropped from the catalog

States:

Not published on the site we reviewed

A named-physician program (Dr. James David Lawrence III, M.D.) with plans starting at $120/mo, free consultations and follow-ups — but no disclosed split between semaglutide and tirzepatide pricing, coverage in 44 states rather than all 50, and a $125 cancellation fee inside a tight 24-hour window.

Semaglutide:

$120/mo starting (not split by molecule)

Tirzepatide:

$120/mo starting (not split by molecule)

States:

44 states + DC (not AK, AR, MA, NM, OR, RI, SC)

Sumbare's pitch is warmth — "a team that celebrates every body" — and one price, "Plans from $120/mo · confirmed after provider review", with nothing broken out by drug or dose. The claim that needs checking is the one under its progress chart: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". Those trials do not exist. Compounded medicines are not FDA-approved and are not put through registrational trials; those figures come from studies of the branded drugs.

Semaglutide:

From $120/mo, not confirmed until after provider review

Tirzepatide:

Not priced separately on the site

States:

Not published — its own counter reads "0 states"

BeyondMD publishes its prices before intake and names eleven clinicians with real bios, both of which are uncommon — but 'Starting at $125' is the floor of a $139-to-$449 band that appears on exactly one page, plus a $34 consultation fee and unpriced shipping, and the number you would actually pay is quoted on a phone call because every GLP-1 button leads to a lead form rather than a cart. Its Terms of Service contain no refund policy, no cancellation policy and no auto-renewal terms at all — the word 'refund' does not appear once in 44 KB.

Semaglutide:

From $125/mo

Tirzepatide:

From $199/mo

States:

Most U.S. states (no list published)

A flat-priced provider naming several individual physicians (including a specifically-credited Medical Director) — $125/mo semaglutide, $145/mo tirzepatide as currently displayed — though the site's own strikethrough pricing presentation leaves it unresolved whether that's a standing rate or a promotional one, so confirm at signup.

Semaglutide:

$125/mo (promotional)

Tirzepatide:

$145/mo (promotional)

States:

Not disclosed — no published state list

⛔ FDA warning letter #716508 (Sept. 2025), which names gobioverse.com. A broader longevity-telehealth platform (also TRT, sexual health, hair loss, skin) pricing GLP-1s at a genuinely low, consistently-stated $129/mo semaglutide and $399/mo tirzepatide — undercut by a real defect on its own homepage, which publishes two different state-coverage lists in two different FAQ answers that don't agree with each other.

Semaglutide:

$129/mo

Tirzepatide:

$399/mo

States:

Two conflicting lists on its own homepage FAQ — 10 states in one answer, 18 in another; confirm your own state directly before paying

The lowest published prices in this group, and shown the plainest way: an open storefront with six figures on it, no account and no intake needed. Microdose semaglutide is $99 a month, microdose tirzepatide $119, standard semaglutide $129 and standard tirzepatide $149, each sold once weekly with vitamin B6, with needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones, which is not true of every seller here. Two things deserve weight against that. The oral drops are sold with no published evidence for the route, and milligrams under the tongue are not interchangeable with milligrams injected. And the same page advertises retatrutide, labeled "GLP-3", as a product coming soon, alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list is published and no dispensing pharmacy is named.

Semaglutide:

$129/mo

Tirzepatide:

$149/mo

States:

Not published

A flat $129/mo semaglutide, $169/mo tirzepatide compounded option with no membership fee and pricing that does not climb with dose — though its own assessment page discloses the intake alone does not create a doctor-patient relationship. Both medications ship through U.S.-licensed providers and clinicians, per its own site copy.

Semaglutide:

$129/mo

Tirzepatide:

$169/mo

States:

Not disclosed — no published state list

DoctorAdam sells GLP-1s only as daily oral tablets — no injection anywhere in its catalog — which makes it a genuinely different option rather than another compounder with a slightly different price. Semaglutide tablets from $129 a month, tirzepatide tablets from $199, delivered to all fifty states with what it calls flat monthly pricing. Read the cards carefully, though: the $129 next to the NAD+ injection is not the GLP-1 figure, and the two sit close together.

Semaglutide:

From $129/mo for the oral tablet

Tirzepatide:

From $199/mo for the oral tablet

States:

All 50 states

"Plans from $129/mo · confirmed after provider review" is the whole of the published pricing — no drug breakdown, no dose breakdown, nothing fixed before an intake. The homepage manages to contradict itself on coverage in a single screen, with a scrolling ticker claiming "50-state telehealth" beside a stat block reading "0 states telehealth access". And the headline result, "~15–20% avg. body-weight change", is sourced to trials of compounded semaglutide and tirzepatide. Those trials do not exist.

Semaglutide:

From $129/mo, not confirmed until after provider review

Tirzepatide:

Not priced separately on the site

States:

Contradicted on its own homepage — "0 states" beside "50-state telehealth"

Names three compounding pharmacies in three separate documents, which is more than most of this market manages — on a site 103 days old that also advertises 2,400 patient reviews we can find no trace of, four different monthly prices, and prepay discounts worth exactly nothing.

Semaglutide:

$130/mo

Tirzepatide:

$180/mo

States:

All 50 states (DC not offered at signup)

A recently-rebranded provider (formerly Piper, now Join Polly) with a flat, dose-independent price for both molecules — $135/mo semaglutide, $199/mo tirzepatide — and one of the few among the providers we track to publicly name its compounding pharmacies (Hallandale Pharmacy, VialsRx).

Semaglutide:

$135/mo

Tirzepatide:

$199/mo

States:

All 50 states

⛔ FDA warning letter #716501 (Sept. 2025), which names getzealthy.com, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here.

Semaglutide:

$135/mo

Tirzepatide:

$225/mo

States:

Most states

Neuve's homepage says "Plans from $127/mo". Its pricing page says "GLP-1 from $138/mo". Neither is the real number, because the page that carries them is titled "Transparent pricing, for members" and asks you to create an account to see it: "Every protocol, dose, and lab panel with its real price — unlocked the moment you create a free NEUVÉ account." The coverage claim disagrees with itself too, 40-plus states in one place and all fifty in two others. Labs start at $45, and membership fees are billed separately from the medication.

Semaglutide:

GLP-1 from $138/mo per the pricing page

Tirzepatide:

Not priced separately on the site

States:

Its own pages disagree — "40+ states" on one, all 50 on two others

Rylo leads with $99.67 a month, which is a quarterly total divided by three — the same arithmetic that makes another entry on this page misleading. The difference is what sits next to it. On the same line it prints "$299 every 3 months · $139 monthly", and under the pricing block it says plainly that the figure reflects the quarterly rate. Then it demonstrates its flat pricing instead of asserting it: month one 2.5 mg, $229; month two 5.0 mg, $229; month three 7.5 mg, $229.

Semaglutide:

$139/mo month to month

Tirzepatide:

$229/mo month to month

States:

Not published; described only as licensed US providers

Velvet Rx publishes three prices and almost nothing else, and the gap between those two facts is the review. The prices are real and stated plainly on its homepage: injectable semaglutide as low as $139 a month, injectable tirzepatide as low as $179, and an oral GLP-1 as low as $189 — which puts it in the cheaper half of this page and makes it one of the few providers here offering an oral formulation alongside the injections. The problem is the phrase 'as low as', which appears on all three and is never resolved. There is no dose ladder, no plan length, no billing cadence, and no pricing page at all: /pricing and /weight-loss both return 404, and the homepage is the only page on the site carrying a number. So $139 is a floor, and nothing published tells you how far above it a maintenance dose sits. The disclosure gaps compound from there. No compounding pharmacy is named, no clinician is named, coverage is not stated, and its own cancellation FAQ asks 'How do cancellations and refunds work?' and answers with 'our care team will guide you with personalized support' — which is not an answer. The operating entity is Rocket Health Inc.; neither the brand nor that entity has an FDA warning letter. Treat the $139 as an opening bid rather than a price.

Semaglutide:

From $139/mo (its own 'as low as' floor)

Tirzepatide:

From $179/mo (its own 'as low as' floor)

States:

Not disclosed

A $139/mo semaglutide or $199/mo tirzepatide standard rate (after a $69/$129 first-month promo), with a genuinely fair, worked-example refund policy for its multi-month prepay plans — undercut by a pricing page with enough overlapping numbers that the real monthly cost takes real effort to pin down, and no named pharmacy.

Semaglutide:

$139/mo

Tirzepatide:

$199/mo

States:

Not verified live — no state list found on the pages checked

A month-to-month, no-subscription compounded shop — from $139.99/mo semaglutide, $179.99/mo tirzepatide — that requires a separate $50 Zoom video consultation before treatment begins, and offers no postpartum or PCOS-specific guidance of any kind on its public pages.

Semaglutide:

From $139.99/mo

Tirzepatide:

From $179.99/mo

States:

Nationwide

"Compounded Semaglutide & Tirzepatide from $145/mo" is the homepage line, and one of those two costs $315. Open the weight-metabolism page and the molecules are priced separately — semaglutide $145 on subscription, tirzepatide $315, or $161 and $350 without it. The "from" is doing more work than a mother comparing options can see, and the site's own header adds to the confusion by claiming treatments start at $157.

Semaglutide:

$145/mo on subscription

Tirzepatide:

$315/mo on subscription

States:

All 50 states

The lowest published starting price we found this round — $147/mo semaglutide, $199/mo tirzepatide, stated plainly as 'no membership costs, no hidden fees, same price all' — but you won't find that number on the marketing site itself; it only shows up once you're routed into the separate signup funnel.

Semaglutide:

$147/mo

Tirzepatide:

$199/mo

States:

Not publicly disclosed

A twenty-year weight-loss operator rather than a telehealth startup, selling compounded semaglutide at $149 a month to month and tirzepatide at $239, medication and clinical care in one price with no separate membership fee. The cheaper $116 and $159 figures it leads with are three-month plans, and there is a catch its own FAQ spells out: those plans bill every ten weeks, not every twelve. That is 5.2 charges a year instead of 4, which turns an advertised $116 a month into roughly $151 a calendar month. Read it as a real discount, just a smaller one than the number suggests. It ships to all 50 states, holds a BMI floor of 26, and excludes anyone pregnant or breastfeeding.

Semaglutide:

$149/mo month-to-month ($116/mo on a 3-month plan)

Tirzepatide:

$239/mo month-to-month ($159/mo on a 3-month plan)

States:

All 50 states

Telehealth GLP-1 programs in all 50 states from $149 a month, including a dedicated microdose protocol alongside standard semaglutide and tirzepatide. That figure is a floor rather than a rate, it is labeled a limited-time offer, and no treatment page publishes a price for any specific molecule, so the real cost is not knowable until you finish a two-minute eligibility check. Superior Remedies charges nothing if you are not approved, titrates the dose to how you respond rather than shipping a fixed refill, and attributes its compounding to state-licensed pharmacies it does not name.

Semaglutide:

From $149/mo (floor)

Tirzepatide:

From $149/mo (floor)

States:

All 50 states

A fully itemized pricing table — as low as $96/mo semaglutide or $142/mo tirzepatide on the annual plan — from the same medical group behind Cora Health, another new addition this batch.

Semaglutide:

$149/mo month-to-month ($96/mo on the 12-month plan)

Tirzepatide:

$219/mo month-to-month ($142/mo on the 12-month plan)

States:

All 50 states

Compounded semaglutide and tirzepatide at one price whatever your dose, which is the part worth having: $149 and $229 a month once you are past the introductory period. The numbers on the cards are lower — $119 and $199 — and those are the intro rates. Coivas is unusual in printing both on the same page rather than making you find the second one on a renewal invoice, and the ongoing figure is the one to budget against. What it does not offer is brand-name Wegovy or Zepbound, an oral option, or any mention of bloodwork, and the word "from" in front of every price is the seller telling you your dose can move it.

Semaglutide:

$149/mo after the intro period, same price at every dose

Tirzepatide:

$229/mo after the intro period, same price at every dose

States:

All 50 states

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though no postpartum or PCOS-specific content.

Semaglutide:

$149-219/mo depending on plan length

Tirzepatide:

$199-319/mo depending on plan length

States:

All 50 states + DC

Compounded semaglutide at $149 a month and tirzepatide at $279, flat across every dose the site lists, from a women's clinic that treats weight as one lane among hormones, perimenopause, gut and skin rather than the whole product. There is a genuine 2.5mg microdose tirzepatide line at $249, which is worth reading twice: it costs only $30 less than the full-dose plan. The prices are on open pages with no quiz in the way, and the BMI floor of 27 is stated up front. Two things to know before you commit. Its own semaglutide page describes the same plan as both month-to-month and four-week, so ask which one your card is on. And the cancellation page linked twice in the top navigation is completely blank.

Semaglutide:

$149/mo

Tirzepatide:

$279/mo ($249/mo microdose)

States:

49 states — not Mississippi

⛔ FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, licensed in all 50 states, though no content addresses postpartum or PCOS.

Semaglutide:

$149/mo standard

Tirzepatide:

$299/mo standard

States:

All 50 states

Compounded semaglutide at $199 a month and tirzepatide at $249, with daily oral dissolving tablets at $149 and $199 for anyone who would rather not inject. The price is genuinely flat across every dose and the billing cycle is a true calendar month, which is less common on this roster than it sounds. The catch is the headline: the $99 and $149 figures the site leads with are a first-order discount only, and the second month is the full rate. Subscription is mandatory despite the site advertising a one-time purchase option, and the injectable products are not browsable — they are reachable only through the quiz or a direct link.

Semaglutide:

$149/mo oral ($199/mo injection)

Tirzepatide:

$199/mo oral ($249/mo injection)

States:

45 states — not Alaska, Arkansas, Mississippi, North Carolina or New Jersey

Compounded semaglutide at $149 and tirzepatide at $183, both advertised as sale prices against $299 and $399, with no membership fee and pharmacies described only as USA-based. ⚠ NativeMed carries an FDA warning letter of its own — issued to NativeMed LLC dba NativeMed on 8 June 2026, MARCS-CMS 728287, for false and misleading claims and misbranding in telehealth. We list it and disclose the letter rather than dropping it, because a letter tells you something a reader should weigh and only a shutdown ends a listing. The storefront also sells NAD+ injections and generic sildenafil, tadalafil and trazodone alongside the GLP-1s, so it is a general telehealth catalog rather than a weight-loss practice.

Semaglutide:

$149/mo (sale, regular $299)

Tirzepatide:

$183/mo (sale, regular $399)

States:

Not published

Rehydra+ Wellness is the one provider added here that charges more as your dose goes up, and it is unusually open about it: its storefront publishes a complete dose-by-duration matrix, so you can see before signing up that compounded semaglutide runs $149 for four weeks at the 0.25 mg starting dose and $289 at 2.5 mg, while tirzepatide runs $219 at 2.5 mg and $649 at 15 mg. That transparency is genuinely useful, and it also means the entry price is the least representative number on the page — if you titrate to an effective dose, your cost roughly doubles. Six-month tier plans bring the per-month figure down to $119 and $169, but they are six-month commitments rather than rolling plans. It is a small San Antonio operation founded in 2023, offering a free 15-minute telehealth call and free shipping. The two real gaps: it names no pharmacy and no individual clinician, and its own pages disagree on coverage — the weight-loss landing page says 19 states and lists 19, while the homepage says 20.

Semaglutide:

$149/mo

Tirzepatide:

$219/mo

States:

19 states (its own pages disagree — one says 20)

A granular GLP-1 menu — microdose from $129/mo, semaglutide from $149/mo, tirzepatide from $249/mo, plus an exclusive combined 'GLP-Squared' injection at the same $249/mo — all stated as all-inclusive, with no postpartum or PCOS-specific content.

Semaglutide:

Starts at $149/mo, all-inclusive

Tirzepatide:

Starts at $249/mo, all-inclusive

States:

All 50 states

"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel." That sentence does something almost nothing else on this page manages: it names the billing period in the same breath as the price, so you can see that a year is thirteen charges rather than twelve. Then you go looking for the terms of use, and find that the link returns the homepage with a different title on it. There is no terms of use.

Semaglutide:

$149 per 4 weeks

Tirzepatide:

$199 per 4 weeks

States:

Not published

LegitScript-certified and available in all 50 states at $149/mo ongoing (after a $124 first month) for compounded semaglutide, with a 3-months-paid-in-full option that brings the equivalent rate to $132/mo — but it's a broad IV-therapy-and-hormone platform first, its own homepage banner prices the same program differently than its product page, and tirzepatide isn't offered as a compounded option. Its wider catalog runs well beyond GLP-1s: women's hormone therapy (estrogen and progesterone), hair regrowth, a Texas-only mobile IV therapy service, and a large general wellness-supplement line all sit on the same site, which is worth knowing if you're looking for a single-purpose GLP-1 program rather than a broad wellness platform whose GLP-1 offering is one line among many.

Semaglutide:

$149/mo

Tirzepatide:

Not offered as compounded — branded Zepbound/Wegovy available on request, price not shown

States:

All 50 states

A Texas-only practice, and it is unusually careful about one distinction most sellers blur: its Wegovy Pill tier is listed as "$99/mo + medication cost", saying outright that the fee is the service and the drug is extra. Compounded semaglutide is $149 a month as either a weekly vial or a needle-free daily tablet. Brand-name Wegovy and Zepbound are offered alongside, which is rare at this price point, though their medication costs are not published.

Semaglutide:

$149/mo for the compounded vial or tablets

Tirzepatide:

Brand-name Zepbound offered; price not published

States:

Texas only

Novi's month-to-month prices are the ones on its product pages — $149 semaglutide, $179 tirzepatide — and every cheaper figure it advertises is a prepay term price divided by its term, including the "from $88/mo" in its own page title. Its homepage headlines "$133/mo" beside a "Was $299" anchor and a countdown claiming the price rises within 24 hours, and its intake serves a higher variant again, so what leaves your account may not be the number you shopped from. Its intake screens for pregnancy, breastfeeding and birth within the last six months — genuinely more than most. But its Terms require a three-month non-refundable commitment while its help center and every marketing page promise you can cancel anytime, and that contradiction is unresolved.

Semaglutide:

$149/mo

Tirzepatide:

$179/mo

States:

All 50 states + DC

Prices by FORM rather than molecule — $149/mo for a compounded injection or $249/mo for a dissolvable tablet, either drug, no membership fee — built on the OpenLoop telehealth backbone, though it doesn't itemize semaglutide vs. tirzepatide separately or publish a state list.

Semaglutide:

$149/mo (form price, not split by molecule)

Tirzepatide:

$149/mo (form price, not split by molecule)

States:

Does not disclose a specific state list

The cheapest advertised sticker price of any owner-named candidate this pass, but the thinnest disclosure too — no state list, no named clinician, no pharmacy — so treat the floor price as a starting point to confirm, not a guarantee.

Semaglutide:

From $149/mo

Tirzepatide:

From $175/mo

States:

Not disclosed — no published state list

$149/mo semaglutide or $199/mo tirzepatide on its recommended Monthly Plan, from two named compounding pharmacies, with a real published cancellation policy (2-day notice) — genuinely one of the more transparent compounders in this batch, though its oral-tablet price wasn't cleanly confirmed.

Semaglutide:

$149/mo

Tirzepatide:

$199/mo

States:

Not published — no state list found anywhere on the site

One of the more straightforward entries on this list, which after a run of sellers quoting months that are not months is worth saying. Compounded semaglutide is from $149 a month and tirzepatide from $224, billed monthly with no four-week cycle hiding behind the wording, and there is $99 off your first treatment plan rather than a rate that doubles later. Coverage is all 50 states and expedited shipping is free. The caveat that remains is the word "from": both figures are floors, medication is prescribed only if a clinician judges it appropriate, and the site does not spell out what a higher dose costs.

Semaglutide:

From $149/mo

Tirzepatide:

From $224/mo

States:

All 50 states

Compounded semaglutide from $149 a month and tirzepatide from $199, with a genuine microdose line at $129 and a dissolving oral tablet at $169 — a wider catalog than most, and it includes hormone therapy for women from $69. The number to ignore is the one it leads with. 'Starting at $99/mo' runs across every page, and no GLP-1 on the site costs $99: the cheapest is the $129 microdose. The $99 belongs to its NAD+ nasal spray. Two more gaps worth knowing. Every price is a floor, with no ongoing rate published. And it names no company anywhere — no LLC, no address, nothing in the terms or privacy policy.

Semaglutide:

From $149/mo — a floor; no month-to-month rate is published

Tirzepatide:

From $199/mo — a floor; no month-to-month rate is published

States:

50 states (claimed)

One of the few candidates verified this pass offering both a cheap compounded entry point ($99/mo semaglutide) and a real brand-name Wegovy/Zepbound fallback, billed upfront per plan length rather than as a monthly subscription — text-only consults, no video visit.

Semaglutide:

$99/mo

Tirzepatide:

$149/mo

States:

Not disclosed — no published state list

A Dallas-area mobile wellness company, not a nationwide telehealth brand — $149/mo semaglutide and $189/mo tirzepatide, flat at every dose, after I re-checked a pricing conflict the affiliate directory had flagged. No PCOS, postpartum, or breastfeeding guidance, and no shipping outside Texas.

Semaglutide:

$149/mo

Tirzepatide:

$189/mo

States:

Dallas/Fort Worth, TX area only — not shipped outside Texas

Semaglutide is advertised as low as $149 a month and tirzepatide at $199, and after previously disagreeing with itself the site now quotes the same figures on the homepage and on each drug page. Read both as floors rather than rates. There is no ceiling published, no dose ladder anywhere on the site, and the three- and six-month bundles are described as carrying stack discounts that are never quantified, so nothing on the public pages lets you work out what treatment costs once your dose settles. The clearest gap is the memberships page, which names tiers and publishes no price for any of them despite the memberships appearing to be how the programs are sold. RENN is a California-based virtual weight-loss and performance clinic that also offers NAD+ therapy, delivering medication directly to patients. The compounding pharmacies are never named, and the only coverage statement is that the website may be accessed from all fifty states, which is a claim about the website rather than about where it is licensed to treat.

Semaglutide:

From $149/mo (floor)

Tirzepatide:

$199/mo

States:

Not published

There is no way to learn what Believe charges without applying to it. Its three GLP-1 treatment pages were read end to end and contain no dollar figure at all, and the only number on the homepage is a badge saying you pay nothing if you are not approved. Behind the eligibility gate the menu is four plans, each flat at every dose: compounded semaglutide at $149 a month against a struck-through $249, compounded tirzepatide at $229 against $299 and labeled most chosen, a GLP-1 microdose at $199, and a daily GLP-1 oral at $229. Those are competitive numbers, and two things complicate them. The microdose costs $50 a month more than standard semaglutide, which is the reverse of what people expect from a lower dose. And two of the four plans never name a molecule at all, so you would be choosing between products without being told which drug is in them. It claims fifty-state care without listing the states and names no dispensing pharmacy.

Semaglutide:

$149/mo after an approved intake

Tirzepatide:

$229/mo after an approved intake

States:

All 50 states, claimed but not enumerated

LunaRx has the most interesting idea in this group and the least reason to be trusted with it. The pitch is muscle-protective: GLP-1 paired with peptides and "a structured off-ramp — metabolic recomposition, not another forever prescription", in English and Spanish, founded by a named nurse. Then you notice its three patient testimonials — Jessica R., Michael T. and Sarah M., with their months and medications — appear word for word on a different company's site. And its own two prices disagree: the page title says $199, the hero says $149.

Semaglutide:

From $149/mo per the hero; the page title says $199

Tirzepatide:

Not priced separately on the site

States:

Not published on the site

The two product cards are clear enough — semaglutide from $149 against a struck $249, tirzepatide from $249 against $299 — but the page around them argues with itself. The hero and the eligibility widget both say "from $99/mo", which is not either card. The header claims "10k+ Trusted by thousands of members" while the counter twenty lines below reads "0 + Patients supported". Four separate statistics on this page render as zero, including a "0.0 /5 Average care rating".

Semaglutide:

From $149/mo

Tirzepatide:

From $249/mo

States:

Not published; described only as "nationwide"

Metaboost publishes two clean per-drug prices — semaglutide from $149 a month, tirzepatide from $199 against a struck-through $299 — which is more than several of its siblings manage. Then you reach the legal pages, where the company address is given three times as "123 Example Street, Suite 100, Your City, WI, 92308". That is an unfilled template placeholder, live, on a site selling prescription medication. The ZIP belongs to California and the state abbreviation to Wisconsin.

Semaglutide:

From $149/mo

Tirzepatide:

From $199/mo

States:

Not published; described only as "nationwide"

Ryze Rx contradicts itself twice on one screen. Its header offers "GLP-1s from $119/mo" and "Testosterone from $89/mo"; the treatment cards immediately below say "From $149/mo" and "From $99/mo" for the same two things. Neither pair is reconciled anywhere. The site is bilingual, which matters for a Spanish-speaking reader and is rare enough to count for something, but there is no state list, no address and no price for tirzepatide at all.

Semaglutide:

From $149/mo per the treatment card

Tirzepatide:

Not priced separately on the site

States:

Not published on the site

One price for either molecule — $149.97 a month, $134.99 on six months, $112.50 on twelve — and the arithmetic is exact. Then the same page tells you its plans start at $249.97, which is a hundred dollars above the most expensive thing it sells. That figure turns out to be the interesting part: the identical orphan number appears on Next Vial, where it contradicts that site's prices too.

Semaglutide:

$149.97/mo

Tirzepatide:

$149.97/mo

States:

Not published

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.

Semaglutide:

$150/mo

Tirzepatide:

$199/mo

States:

All 50 states

The prices are ordinary — $150 for compounded semaglutide, $240 for tirzepatide, $150 for an oral liposomal version. The statistics around them are not. LevelsRx's "94.6% success rate" and "14+ lbs avg. weight loss" rest on a footnote citing "approximately 66,260 Remedy Meds members" — a different company, the white-label platform this site runs on. A second footnote on the same page gives the sample as "approximately 50,000 members". And the live review widget reads: 6 reviews, 1 member.

Semaglutide:

From $150/mo

Tirzepatide:

From $240/mo

States:

Not published; described only as "Nationwide"

PepHaus writes a sentence most of this roster cannot: "Every price is on the site." Semaglutide from $152 a month, tirzepatide from $215, and the site is explicit that one flat monthly price covers the provider visit, the medication, needles, alcohol swabs and messaging with the care team. It also does something almost nobody does — a Certificate of Analysis on every vial. One thing to watch: the "From $143/mo" in the hero is sermorelin and glutathione, not a GLP-1.

Semaglutide:

From $152/mo, all-inclusive

Tirzepatide:

From $215/mo, all-inclusive

States:

Not published on the site

A straightforward compounded-only shop with real prices for every tier posted on the public site — no intake gate — but the 'Starter Pack' name is a trap if you assume it behaves like the regular 3-month plan.

Semaglutide:

$159/mo (1-month), $119/mo effective on the 3-month plan

Tirzepatide:

$249/mo (1-month), $200/mo effective on the 3-month plan

States:

All 50 states + Puerto Rico

A dose-by-dose price ladder Coby publishes outright — $159/mo semaglutide climbing to $249/mo at full dose, $239/mo tirzepatide climbing to $439/mo — with no membership fee and free shipping, but four states (Arkansas, Louisiana, Mississippi, New Mexico) it names as excluded and no maternal-health framing anywhere on the site.

Semaglutide:

From $159/mo

Tirzepatide:

From $239/mo

States:

Most states and major metros; excludes Arkansas, Louisiana, Mississippi and New Mexico per its own site

A comprehensive-care-focused shop — $130-160/mo semaglutide, $163-199/mo tirzepatide — that bundles unlimited provider messaging and a broader longevity menu (NAD+, Sermorelin, B12) alongside the core GLP-1 pricing.

Semaglutide:

$160/mo on the 1-month plan ($130/mo on the 3-month plan)

Tirzepatide:

$199/mo on the 1-month plan ($163/mo on the 3-month plan)

States:

All 50 states

An MD-led, budget-friendly compounded shop that names its pharmacy partners — around $165/mo semaglutide or $200/mo tirzepatide standard — though pricing is packaged in 12-week blocks and there's no postpartum or PCOS-specific content.

Semaglutide:

$165/mo (12-week package)

Tirzepatide:

$200/mo (12-week package)

States:

All 50 states + DC

Remote Pharmacy's homepage says weight loss starts "for as little as $287/month". Its weight-loss page says compounded semaglutide is "as low as $167/Month". Both are its own claims, and the cheap one is the accurate one — an unusual direction for a pricing error, and worth knowing before you take the homepage figure as the floor. Sublingual tablets are offered alongside the injection at the same prices, and the branded pens are listed but marked Coming Soon.

Semaglutide:

$167/mo for the compounded injection

Tirzepatide:

$229.99/mo for the compounded form

States:

Not published on the site

The one confirmed nationwide pick in this batch — all 50 states, explicitly stated — with a $168/mo semaglutide, $268/mo tirzepatide month-to-month rate that only drops to $129/$199 on a full year prepaid upfront.

Semaglutide:

$168/mo

Tirzepatide:

$268/mo

States:

All 50 states

Two columns, headed Program and Medication, and both filled in. The program is $99 a month and covers every visit, the check-ins, the coaching and 3D body composition testing; the medication is separate and starts at $70. Almost everything else on this page either folds the fee into the drug price or leaves you to discover it. The honest total is about $169, and the only soft edge is that $70 is itself a starting figure.

Semaglutide:

$169/mo — $99 program plus medication from $70

Tirzepatide:

$169/mo on the same basis

States:

A Texas practice in The Woodlands

Compounded semaglutide at $169 and tirzepatide at $249, with genuine microdose lines beneath both at $149 and $199, all on an open pricing page you reach without an intake quiz. It names its clinical group and its pharmacy outright, which most of this roster will not do. Two cautions before you compare it with anything else here. Its pricing page puts a per-month suffix on its three-month and six-month columns, where the number is actually the whole period's total — its own product pages divide those same figures by six. And nowhere does it say how long a billing period is, so the prices above are per period, not per calendar month.

Semaglutide:

$169 per billing period — length not disclosed

Tirzepatide:

$249 per billing period — length not disclosed

States:

Does not disclose a service area

Two things here are genuinely unusual. Tirzepatide costs the same as semaglutide — both from $169 a month — where nearly every other seller charges a premium of fifty to a hundred dollars for the dual-agonist. And Lighter You names four compounding pharmacies in full, with street addresses and phone numbers: RedRock, Health Warehouse, Precision Compounding and Triad Rx. Most of this roster names none. Coverage is all fifty states plus Washington, D.C.

Semaglutide:

From $169/mo

Tirzepatide:

From $169/mo

States:

All 50 states plus Washington, D.C.

A single semaglutide-plus-B12 product (SKU COMP-GLP1 on Actin's own site) with no tirzepatide option, priced $169/mo month-to-month, about $143/mo on a 3-month plan, and about $116/mo on a 6-month plan depending on which term you pick, inside a broader hormone, sexual-wellness, and hair-health platform where the GLP-1 line is one product among many rather than the company's focus — there's no LegitScript badge, no named compounding pharmacy, no lab work or video visit required to start, and the exact price stays hidden behind a 'GLP-1 Precision Match' intake quiz until after you answer its questions.

Semaglutide:

$169/mo

Tirzepatide:

Not offered — semaglutide only

States:

Not disclosed — no published state list

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and there's no postpartum or PCOS-specific content.

Semaglutide:

$170/mo ongoing (injectable)

Tirzepatide:

$210/mo ongoing (injectable)

States:

All 50 states + DC

A flat $174/mo semaglutide and $264/mo tirzepatide with a named physician (Beluga Health's Dr. Jonah Mink) and a named compounding pharmacy (F&F Pharmacies) behind it — undercut by a real arithmetic mismatch on its own page, where a claimed 44-state coverage area doesn't reconcile with its own 10-state exclusion list.

Semaglutide:

$174/mo

Tirzepatide:

$264/mo

States:

Claims 44 states; excludes CA, NV, NJ, NC, TX, MA, MS, NH, WV, DE — though 50 minus those 10 is 40, not 44, a real arithmetic mismatch on its own page

An $89/mo Direct Primary Care membership unlocks metered GLP-1 pricing here — $174/mo all-in for the lowest semaglutide dose, $222/mo for the lowest tirzepatide dose, rising to $272/$347 at the top doses — bundling in unlimited primary care, direct clinician texting, same-day virtual visits, and routine labs across 18 confirmed service areas. No stated refund policy on the membership itself, and nothing written for postpartum or PCOS specifically. Its real pricing tiers appear only once the page's scripts run, never in the marketing copy itself.

Semaglutide:

$174/mo all-in

Tirzepatide:

$222/mo all-in

States:

AZ, CO, DC, FL, GA, IA, ID, KS, MT, NE, NM, NV, NY, OK, OR, UT, VA, WA (18 areas; more coming per its own FAQ)

The most transparently tiered pricing found in this batch — as low as $99/mo semaglutide or $135/mo tirzepatide on the annual plan, with every tier itemized publicly — from a platform with a thin 36-review Trustpilot count so far.

Semaglutide:

$175/mo month-to-month ($99/mo on the annual plan)

Tirzepatide:

$225/mo month-to-month ($135/mo on the annual plan)

States:

All 50 states

Publishes its entire price ladder and names both its compounding pharmacy and its prescribing practice — and, as of August 21, 2026, every signup button on the site leads to a 404, so none of that is reachable.

Semaglutide:

$175/mo

Tirzepatide:

$225/mo

States:

All 50 states (video visit required in some)

A $175/mo semaglutide, $199/mo tirzepatide compounded option carrying its own FDA warning letter (September 2025) for a 'same active ingredient as Wegovy & Ozempic' claim the FDA called misleading.

Semaglutide:

$175/mo

Tirzepatide:

$199/mo

States:

Not disclosed — no published state list

A clean, all-inclusive flat-price shop — $179/mo semaglutide, $249/mo tirzepatide, unlimited follow-ups included — with no brand-name fallback and no postpartum or PCOS-specific content.

Semaglutide:

$179/mo all-inclusive

Tirzepatide:

$249/mo all-inclusive

States:

Nationwide

This is a real surgical practice rather than a telehealth brand — a Hollywood, Florida bariatric center with a named surgeon, doing gastric sleeves and bypasses alongside the injections. Semaglutide runs $69 a week or $179 a month; tirzepatide starts at $279. Two things need care. Its package labels overstate their own length — "2.5-Month (10 Weeks)" is 2.3 months and "5-Month (20 Weeks)" is 4.6 — and the practice markets retatrutide, a drug that is not approved anywhere for anything.

Semaglutide:

$179/mo for the monthly program

Tirzepatide:

From $279/mo

States:

A Florida surgical practice offering telehealth; no state list published

A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed, and there's no postpartum or PCOS-specific content anywhere on the site's public pages, which is worth knowing before you start.

Semaglutide:

From $179/mo

Tirzepatide:

From $255/mo

States:

Nationwide

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear, and there's no postpartum or PCOS-specific content.

Semaglutide:

$179/mo compounded

Tirzepatide:

$239/mo compounded

States:

Nationwide

⛔ FDA warning letter #721449 (Feb. 2026), which names goodgirlrx.com. Six formats across two molecules — injectable, microdose, and oral dissolving tablets — all-inclusive of medication, supplies, and shipping, starting at $134/mo; nothing on-site addresses pregnancy, breastfeeding, or PCOS.

Semaglutide:

$179/mo on the 1-month plan ($134/mo on the 12-month annual plan)

Tirzepatide:

$235/mo (annual plan)

States:

Not disclosed

A flat-price compounded shop — $179/mo semaglutide, $259/mo tirzepatide, same price at any dose — though the site doesn't itemize what's actually bundled into that number, and offers no postpartum or PCOS-specific content.

Semaglutide:

$179/mo, same price any dose

Tirzepatide:

$259/mo, same price any dose

States:

Nationwide

A named-founder telehealth program ($179/mo semaglutide, $249/mo tirzepatide regular price) with no consultation or membership fees, 24/7 provider messaging and free 2-day shipping — undercut by a countdown-timer intro-rate tactic and a state-coverage claim that's actually its pharmacy's licensing, not its own.

Semaglutide:

$179/mo

Tirzepatide:

$249/mo

States:

Does not disclose its own state list (only its pharmacy's licensing)

An uncommon needle-free option — both semaglutide and tirzepatide sold as an oral tablet as well as an injection — with all-50-states coverage clearly disclosed, though its $179/mo semaglutide rate is explicitly a promo and its headline weight-loss stats are self-reported, not clinical.

Semaglutide:

$179/mo

Tirzepatide:

$249/mo

States:

All 50 states

Publishes a floor and calls it a price — read live on August 21, 2026 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it has no FDA warning letter. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing.

Semaglutide:

$179/mo

Tirzepatide:

$329/mo

States:

Not stated on the site

Every price TrimRx publishes is an entry price, and it publishes nothing else — semaglutide "Starting at $179" and tirzepatide "Starting at $259" on the homepage, "Starting at $149" on a second funnel running the same day, a /pricing page that renders blank, and Terms that contain no pricing at all. There is no ongoing or post-first-month rate anywhere on the site, and that absence is the finding rather than a gap in our checking. Pricing is flat across doses and there is no cancellation fee, both of which we verified rather than took on faith. The 35-screen intake never once asks whether you are pregnant or breastfeeding.

Semaglutide:

From $179/mo

Tirzepatide:

From $259/mo

States:

All 50 states

Compounded semaglutide from $179/mo or tirzepatide from $279/mo on LivBody's per-drug price cards — but its own FAQ separately advertises the whole program at '$249/month,' a real, unresolved inconsistency the site never reconciles, and its Terms of Service collect payment before the consult and call every fee non-refundable 'in whole or in part.' No state list is published; availability is determined during intake.

Semaglutide:

$179/mo

Tirzepatide:

$279/mo

States:

Not publicly disclosed; determined during intake

$183/mo semaglutide or $268/mo tirzepatide, with quarterly labs and coaching genuinely bundled into that price and four named compounding pharmacies — well-documented, though nothing here is written specifically for postpartum or PCOS.

Semaglutide:

$183/mo

Tirzepatide:

$268/mo

States:

All 50 states + DC

One of the very few providers here that names both its pharmacies and its medical director on purpose — and does not mention that the pharmacy it names for GLP-1 fills has been on California Board of Pharmacy probation since 2023. Written throughout for men.

Semaglutide:

$189/mo

Tirzepatide:

$249/mo

States:

48 states (not AK or HI)

A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.

Semaglutide:

Ozempic® from $345/mo

Tirzepatide:

Compounded from $189/mo

States:

48 states (not AL or MS)

Dose-scaling compounded pricing starting at $189/mo semaglutide or $199/mo tirzepatide and rising with each dose tier, verified directly from the site's own production data — including an exact 48-state list (all but Alabama and Mississippi) and a confirmed cancel-or-pause-anytime policy with no hidden fee.

Semaglutide:

$189/mo starting

Tirzepatide:

$199/mo starting

States:

48 states (all except AL and MS)

A concierge functional-medicine platform that bundles a 91-biomarker lab panel into GLP-1 care — $189/mo semaglutide, $339/mo tirzepatide (both $149 the first month) — with real hormone-optimization options, but nothing built specifically for PCOS or postpartum metabolic changes.

Semaglutide:

$189/mo

Tirzepatide:

$339/mo

States:

45 states for tirzepatide (not AK, AR, IN, MN, SC); semaglutide state list not separately disclosed

Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath them reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan at all: a three-month minimum applies and the plan renews every three months. The terms then compound it by referring repeatedly to a different company's website and listing prices that match nothing on the product pages. What is genuinely strong is easy to miss underneath all that. VevaRX enumerates thirty-six states by name rather than claiming fifty, it locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping.

Semaglutide:

$189/mo

Tirzepatide:

$155.67/mo, sold only as a 3-month plan

States:

36 states, enumerated

Somira does the thing almost nobody does: it shows the quarterly price and the division in the same breath — "$136.66 / month ($409.99 / quarter)" — so you can see that the smaller number is a three-month prepayment before you click anything. The plain monthly rate is $189.99 for semaglutide and $239.99 for tirzepatide, syringes and alcohol wipes included, and the site states that your price does not rise as your dose does. After a run of sellers quoting quarters as months, this is what the honest version looks like.

Semaglutide:

$189.99/mo on the monthly plan

Tirzepatide:

$239.99/mo on the monthly plan

States:

Not stated on the site

Compounded semaglutide at $190 a month and tirzepatide at $275, the same price at every dose, medication and clinician access included — and then something no one else here does: the price drops the longer you stay consistent. Its own pricing page publishes the whole ladder, 10% off at a ten-day streak, 20% at twenty, 30% at thirty, which takes semaglutide down to $133 and tirzepatide to $192. Two things to weigh. The $190 and $275 are what you actually start on, so treat the low numbers as a discount you have to earn and keep. And nowhere on that page does it say what counts as a streak or what breaks one, which is the first thing worth asking.

Semaglutide:

$190/mo standard, before streak discounts

Tirzepatide:

$275/mo standard, before streak discounts

States:

50 states (claimed)

Starting From $190/mo semaglutide and $239/mo tirzepatide, with two named compounding pharmacies and a genuine self-serve cancel-anytime policy — but no published state list and nothing addressing pregnancy or breastfeeding.

Semaglutide:

$190/mo

Tirzepatide:

$239/mo

States:

US only — no published state list; the site says restrictions vary by the specific therapy prescribed

A general prescription menu with a GLP-1 line inside it — metformin from $25, testosterone therapy, sermorelin, NAD+ and glutathione alongside the weight-loss plans. Compounded semaglutide is $190 a month and tirzepatide $239, both published before any intake, both flat as the dose titrates, and both with shipping included, which makes them straightforward to compare. The care is needed on the longer supplies. Clicking through the options returns $171, $426 and $1,092 against $190 for thirty days, and the site never states whether those are totals or per-month rates. The $171 sits below the 30-day price, so it cannot be a ninety-day total, and rather than guess which reading is intended only the 30-day figures are treated here as prices. Beyond that the gaps are ordinary for this list: the compounding pharmacies are described as accredited and never named, and no state list is published. Disputes run under Georgia law with arbitration in San Diego.

Semaglutide:

$190/mo

Tirzepatide:

$239/mo

States:

Not published

One of the few programs on this list selling both compounded semaglutide/tirzepatide (from $192.50/$210 a month) and the FDA-approved brand pens (Wegovy, Zepbound) itself — plus real transparency about who runs it — but it doesn't publish a state list, so you won't know if it reaches you until you start the intake.

Semaglutide:

$192.50/mo

Tirzepatide:

$210/mo

States:

Not publicly disclosed; confirmed during intake

This is the most detailed price ladder on the page, and reading it carefully changes what you conclude. Semaglutide runs $195, $225, $265, $290, $310 as the dose climbs — except levels three and four cover five weeks rather than four, which makes level three cheaper per week than level two despite the higher dose. And the sentence above the table says the prices cover four weeks, which is wrong for two of its own five rows.

Semaglutide:

$195 per 4 weeks at the lowest dose, rising to $310

Tirzepatide:

$280 per 4 weeks at the lowest dose, rising to $525

States:

Published per provider, not site-wide; one is listed for Michigan and Ohio

One flat $195/mo price for compounded GLP-1 therapy, injection or sublingual, regardless of which molecule — plus a brand-name lane (Ozempic, Wegovy, Mounjaro) for mothers who want an on-label pen instead. Its full pricing only renders inside the signup flow, and the state list isn't published.

Semaglutide:

$195/mo flat

Tirzepatide:

$195/mo flat

States:

Multiple states (not fully enumerated — confirm yours before signing up)

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

Semaglutide:

$196/mo

Tirzepatide:

$296/mo

States:

All 50 states

This is Bryan Johnson's longevity company, and it sells GLP-1s the way it sells everything else: as a stocked catalog with a price on each item. Compounded semaglutide with glycine and B12 is $167 a month at a microdose and $196 at a personalized dose; tirzepatide is $180 and $255. Brand-name sits alongside it — Zepbound KwikPen $600, Wegovy $1,550, Foundayo $750. The condition is in a footnote on the same card: "Billed quarterly with a three-month commitment paid up front." So the first charge is three months, not one.

Semaglutide:

$196/mo for the personalized dose, billed quarterly

Tirzepatide:

$255/mo for the personalized dose, billed quarterly

States:

Not published as a list; some states require a video consult

Starting prices of $197/mo semaglutide and $297/mo tirzepatide, compounded in the USA with free shipping and no hidden fees stated directly — verified by pulling the site's own compiled app data since its pricing doesn't render in a plain page fetch. No state list is published anywhere we could find.

Semaglutide:

From $197/mo

Tirzepatide:

From $297/mo

States:

Not disclosed on the public marketing page we reviewed

Start with what will otherwise confuse you: this is not Nova MD. Different operator, different owners, and Nova MD is the one carrying an FDA warning letter naming its own domain — this company carries none. What Nova sells is a required $99 monthly membership plus medication, quoted all-in on the product pages at $169 a month for a daily semaglutide oral dose, $174 for the daily tirzepatide oral dose, $198 for the weekly semaglutide injection and $210 for the weekly tirzepatide injection. Offering a daily oral route alongside the weekly shot is genuinely useful, and coverage has just widened to forty-nine states with California still to come. Then the pricing stops agreeing with itself. The semaglutide page leads with $198 above an FAQ headed "What does the $229/mo include?", and the tirzepatide page repeats the trick, leading with $210 above an FAQ headed "$279/mo". Two further products, the needle-free weekly tablets, are advertised in the navigation while both of their pages load almost empty and carry no price at all. And the pricing page promises you are charged only if a provider prescribes, while the refund policy says the consultation and membership fees are not refundable even when the provider declines you.

Semaglutide:

$198/mo all-in

Tirzepatide:

$210/mo all-in

States:

49 states — California excluded

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

Semaglutide:

$199/mo, same price at every dose

Tirzepatide:

$299/mo, same price at every dose

States:

All 50 states

A menopause clinic that treats GLP-1 weight care as a menopause problem, which almost nothing else on this roster does. Four routes are published with prices attached: semaglutide injection at $199 a month, semaglutide dissolving tablets at $279, tirzepatide injection at $249 and tirzepatide sublingual drops at $229, flat at every dose, with anti-nausea support included free for the first two months. The catch is a real one and it is not hidden in the small print so much as split across two pages. The weight page promises no membership and one all-in price; the Terms you actually agree to describe membership plans, recurring charges, and medication billed separately on top. Get which one applies to you in writing before you subscribe.

Semaglutide:

$199/mo injection ($279/mo oral tablet)

Tirzepatide:

$229/mo sublingual ($249/mo injection)

States:

Does not disclose — availability is described only as varying by state

Three pages of this site quote three different prices for the same treatment: the homepage says semaglutide starts at $169 a month, the packages page shows $169 for month one and $199 from month two, and the semaglutide page says the program "typically ranges from $200-$550 per month" — a ceiling nothing on the site comes near. The packages page is the one to trust, and to its credit every plan total on it recomputes to the exact dollar. It also, on the oral semaglutide cards, tells you that what you will receive is tirzepatide.

Semaglutide:

$199/mo

Tirzepatide:

$259/mo

States:

Not published; describes itself as serving patients nationwide

A small, physician-led practice — Dr. Tran Le personally, capped at ~500 patients — $199/mo semaglutide, $249/mo tirzepatide, all-inclusive, but limited to Texas and Utah only, with no content addressing postpartum or PCOS.

Semaglutide:

$199/mo, all-inclusive

Tirzepatide:

$249/mo, all-inclusive

States:

Texas & Utah only

The plan selector is clean: $199 a month, or $169, $149 and $99 on three-, six- and twelve-month plans, and every one of those divisions checks out to the dollar. Semaglutide and tirzepatide cost exactly the same, which is unusual. Then look at the top of the same page, where the headline reads "Doctor-Led Weight Loss Plans as Low as $249.97/Month" — a figure the selector never shows, and two and a half times the cheapest plan it offers.

Semaglutide:

$199/mo month to month

Tirzepatide:

$199/mo month to month

States:

Not published

A named, NPI-verifiable physician (Dr. Michael Mimlitz, MD) backs a standard $199/mo semaglutide and $299/mo tirzepatide rate — the ad copy leads with a $50-off first-month promo, but the page itself discloses the real ongoing number. It also runs a separate brand-name-access pathway, though that one publishes no price.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Nationwide, per its own site

The whole price ladder is on the page before you enter anything, which almost nothing else here does: compounded semaglutide at $199 a month, $549 for three months, $999 for six and $1,788 for twelve, and tirzepatide at $299, $797, $1,494 and $2,748. Read the long plans as what they are. Each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 semaglutide means paying a full year before the first box ships. Disclosure is better than average in the places that matter: Andrew Meds LLC is named with a Houston address, and the practice that actually writes the prescription is named separately as Dr Tel X, with its own address in Kennewick, Washington. Coverage is all fifty states and the District of Columbia, listed out rather than claimed as a number. It also sells an oral tirzepatide. The gaps are the compounding pharmacy, which is never named, and the refund policy, which returns nothing on a period you have partly used.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

All 50 states and DC, enumerated

A flat-price program ($149 first month, then $199/mo, or $165/mo on a 3-month plan) that doesn't split pricing by molecule, with dose adjustments and clinician messaging included and a genuinely strong 100%-refund-if-not-approved, 90-day money-back guarantee — though it publishes no state list.

Semaglutide:

$199/mo (flat program price, not split by molecule)

Tirzepatide:

$199/mo (flat program price, not split by molecule)

States:

Does not disclose a specific state list

Compounded semaglutide at a standard $199 a month and tirzepatide at $299, medication included, with a genuine microdose line underneath at $79. The promotional rates it leads with are $119 and $219. Two things worth knowing before you compare it with anything else here. It serves 26 states rather than all 50, and it does not publish which. And the '$49/mo' on most of its medication cards is a membership fee with the medication paid separately — that lane covers Wegovy, Ozempic, Zepbound and Mounjaro, and the drug cost is never shown. It carries a February 2026 FDA warning letter, cited partly for putting its own name on the pictured vial, which it has since fixed. What it does better than most: a registered dietitian is included for every patient.

Semaglutide:

$199/mo standard, medication included

Tirzepatide:

$299/mo standard, medication included

States:

26 states — the list is not published

Compounded semaglutide at $199/mo and tirzepatide at $299/mo once the first-month promo ends, from a named legal entity (NiceRx LLC, Boca Raton FL) with a live LegitScript verification badge and batch sterility/potency testing — one of the more transparently run compounded programs we've checked, though it says nothing about pregnancy, breastfeeding, or PCOS specifically.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

46 states — not available in Alaska, Mississippi, New Jersey, or Kansas

A broader wellness platform (GLP-1s plus NAD+, sermorelin, HRT, hair growth) offering both compounded ($199/mo semaglutide, $299/mo tirzepatide) and brand-name Ozempic/Zepbound access — though the site shows three different, unreconciled price claims across its own pages, so confirm the real number at signup. The three are the $199/mo standing tier, a $169/mo three-month prepay plan badged 'Best Value', and a countdown-timer banner advertising 'as low as $119/mo' that matches neither. Brand-name access is listed only as 'also available', with no price shown on any page we checked, so the compounded tiers are the only figures you can plan around.

Semaglutide:

$199/mo standard

Tirzepatide:

$299/mo

States:

Nationwide (stated on homepage)

Compounded semaglutide at $199 a month to month, the same price at every dose, with medication, clinician support and two-day shipping in the one price and no membership fee. The $139.99 the site advertises everywhere is not that rate: its own product page shows it is the three-month plan, and first-time-patient pricing on top of that. A returning patient on a monthly plan pays $199. Tirzepatide starts at $199 but its month-to-month rate is not published anywhere. Worth knowing too that the same figure appears three different ways across the site — $139.99, $140 and $139 — and that the $249 and $469 shown beside them are struck-through anchors rather than prices it charges.

Semaglutide:

$199/mo month-to-month, same price at every dose

Tirzepatide:

From $199/mo — a floor; the month-to-month rate is not published

States:

Does not publish a service area

A cash-pay compounded program with FDA-registered-facility and 503A-pharmacy badges and a real 6-month-plan discount ($199/mo semaglutide, $299/mo tirzepatide down to about $176/mo) — undercut by a genuine self-contradiction on its own site about which states it actually serves.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Ascend Vitality's own site contradicts itself

A concierge medicine practice (in-person in LA, NY, and 25+ cities, plus nationwide mail) offering compounded semaglutide at $199/mo (90-day shipments) and tirzepatide at $299/mo (60-day shipments), each locked to a 4-month minimum commitment — and, unusually for this roster, brand-name Ozempic, Wegovy, Mounjaro, and Zepbound at $1,999/mo for mothers who want the FDA-approved product instead of a compound.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not disclosed as a list — ships nationwide via its "Shipped To You" mail program; in-person concierge visits in LA, NY, and 25+ cities

The semaglutide page has a section headed "Transparent Pricing". It prices low-dose naltrexone, twelve strengths of methylene blue and thirteen testosterone combinations. It does not price semaglutide. The semaglutide figure, $99, sits further up and covers "your first 4 weeks" — an intro price with no published successor, over a period that is not a month. Tirzepatide is the one number here that is fully specified: $199 a month, including consultation, medication, supplies and shipping.

Semaglutide:

$99 for the first four weeks; ongoing rate not published

Tirzepatide:

$199/mo

States:

Not published

Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on August 21, 2026, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and none of the three has an FDA warning letter.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not stated on the site

A multi-vertical telehealth platform offering both injectable ($199/mo semaglutide, $299/mo tirzepatide) and a cheaper oral option for each molecule — a genuinely uncommon needle-free path — but with ambiguous FDA-adjacent marketing language, inconsistent self-reported customer counts, and no published state list.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Does not disclose a specific state list

A named-physician compounded program — $199/mo ongoing semaglutide after a $99 six-week intro, and a $330 one-time six-week tirzepatide supply — that includes self-administration supplies in the price, but doesn't publish a state list and still shows a stale 2023 copyright in its footer.

Semaglutide:

$199/mo

Tirzepatide:

$330 one-time (6-week supply)

States:

Not disclosed

$199/mo semaglutide, $299/mo tirzepatide, three named co-founders (Gabriel Mullins, Sara Yoder, Tyler Bowman), no contracts, and a nurse practitioner reviewing intake within roughly 24 hours by Spry's own claim — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, no pharmacy named, no state list disclosed, and nothing written for postpartum or PCOS specifically. Its pricing appears only once the page's scripts run, never in the visible marketing copy.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not disclosed

TeleClinic's whole pitch is a promise called Price-Lock: "The price you start with is the price you keep." Printed directly above that sentence is a table reading "Intro rate (first quarter) $139/mo · Standard rate $199/mo." Both cannot be true. Read the feature list underneath and the lock turns out to be about dose — titrate up without paying more — not about the introductory rate, which does expire. The $79 first month for semaglutide is real, the flat-across-doses pricing is real, and 47 states is a wide footprint. Just do not read "locked from day one" as a promise about $79.

Semaglutide:

$199/mo standard rate, not broken out by drug

Tirzepatide:

$199/mo standard rate, not broken out by drug

States:

47 states — not California, South Carolina or New Jersey

A Delaware-registered program naming four real physicians, with semaglutide and tirzepatide each offered as an injection or oral tablet from a disclosed floor price ($199/$259 'as low as') — but no full pricing ladder, no state list, and no confirmation the required consult is included.

Semaglutide:

As low as $199/mo

Tirzepatide:

As low as $259/mo

States:

Not disclosed

LegitScript-certified compounded semaglutide and tirzepatide at a flat $199/mo and $299/mo regardless of dose, with a $99/mo and $183/mo promo shown on-page — a reasonably transparent flat-rate program let down by no disclosed physical address or named pharmacy, and no mention of pregnancy, breastfeeding, or PCOS.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not available in New Jersey, Alaska, or Mississippi

The only seller here aimed squarely at women, and the one whose advertised price is furthest from what it actually charges. The banner reads "GLP-1 weight care for women from $149/mo" and no program on the site costs $149. Its own program catalog prices semaglutide at $199, the GLP-1 microdose track at $249 and tirzepatide at $349, which means the $199 printed on the tirzepatide card is really the semaglutide rate and the true gap on tirzepatide is $150 a month. The microdose program, which most people reach for to spend less, costs $50 a month more than standard semaglutide. Alinwell LLC is named plainly in its own terms, which is more than several listings here manage, and pricing is flat once you are on a program. Two social-proof badges, a 4.8 Trustpilot rating and a 4.9 Google rating, could not be matched to any profile, and no state list or compounding pharmacy is published anywhere.

Semaglutide:

$199/mo

Tirzepatide:

$349/mo

States:

Not published

Read the pricing line on Clyr's own card slowly, because it contains two things that pull against each other: "$149 first month. Then $199/mo on 8-week cycles." A monthly rate and an eight-week billing cycle are not the same unit, and the site never says how they reconcile — so what a year actually costs cannot be worked out from the page. The other half of the same line is "Tier 2 from $399" with "dose-tiered pricing" beside it, which means the $199 is a starting tier and the bill rises as your dose does. Both medications come compounded with B12, cancellation is stated as anytime, and the catalog runs well past GLP-1s into NAD+, sermorelin and sexual health.

Semaglutide:

$199 after the first month, on 8-week cycles

Tirzepatide:

$199 after the first month, on 8-week cycles

States:

Not stated on the site

The two prices on Oria's front page are not prices you can buy. It advertises a compounded GLP-1 from $149 a month and a dual GLP-1 and GIP from $249, and neither figure appears anywhere on the plan menu at checkout, where the real rates are $199 for semaglutide with B12 and $369 for tirzepatide with B12, both flat across dose levels with shipping included. A second oddity is worth knowing before you commit: on semaglutide the three- and six-month plans are $209 a month, more than the $199 you would pay month to month, and they ship every three months rather than monthly, so committing longer costs more and delivers less often. Against that sits something genuinely good. Oria names its dispensing pharmacy outright, PerfectRx of Flower Mound, Texas, which most compounded sellers on this list never do. It also never names the molecule anywhere on its public site: neither drug appears on the homepage, the terms or the refund policy, and you learn which one you are buying only at the second step of the intake.

Semaglutide:

$199/mo

Tirzepatide:

$369/mo

States:

Not published

A clearly labeled $199/mo semaglutide or $299/mo tirzepatide month-to-month, dropping to $89/$129 only with a 6-month prepay commitment — through a named clinical network (MD Integrations) but no named pharmacy and no published cancellation policy. It's a single-purpose, compounded-only site with no TRT, hair-loss, or mental-health add-ons crowding the page, and its Terms of Service route disputes to the laws of the State of Florida rather than staying silent on jurisdiction.

Semaglutide:

$199/mo

Tirzepatide:

$299/mo

States:

Not published — no state list found anywhere on the site

One price is published here — "Plans from $199/mo · confirmed after provider review" — with no breakdown by drug or dose, and the stat block beside it reads "0 states telehealth access", an unfilled counter left live on the homepage. The claim that needs the most scrutiny is the headline one: "~15–20% avg. body-weight change", which the site attributes to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". No such trials exist. Compounded drugs are not FDA-approved and do not go through registrational trials; those percentages come from studies of the branded products.

Semaglutide:

From $199/mo, not confirmed until after provider review

Tirzepatide:

Not priced separately on the site

States:

Not published — its own counter reads "0 states"

A concierge weight-loss and hormone clinic with lab-guided dosing and a named PA-C, at $200/mo semaglutide or $250/mo tirzepatide — undercut by a narrow 5-state telehealth footprint and homepage copy that inaccurately calls its compounded product 'FDA-approved.'

Semaglutide:

$200/mo (compounded)

Tirzepatide:

$250/mo (compounded)

States:

Telehealth in MO, IA, KS, UT, WA; in-person in Joplin, MO

The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site.

Semaglutide:

$209/mo

Tirzepatide:

$309/mo

States:

All 50 states

"Starting at $49/week — no hidden fees" is the pitch, and the unit is the thing to notice: forty-nine dollars a week is about $212 a month, which is mid-range rather than cheap. The other number to weigh is the one presented as a result. "20% Avg body weight lost" sits in the statistics strip as though it were this service's own average across ten thousand members — 20% is roughly what tirzepatide achieved at its highest dose in a controlled trial, and no telehealth service has published an average like it.

Semaglutide:

$212/mo, billed as $49/week

Tirzepatide:

$212/mo, billed as $49/week

States:

Ships nationwide, per the site; no state list published

"As low as $140/mo" carries an asterisk, and to this seller's credit the asterisk says what it means: with purchase of an annual plan. Month to month is $214.95 for semaglutide and $259.95 for tirzepatide — 53% higher, the same ratio for both. It also does something no other seller here does: it holds your card rather than charging it, and only takes payment if a doctor writes the prescription.

Semaglutide:

$214.95/mo month to month

Tirzepatide:

$259.95/mo month to month

States:

Not published

A five-state compounded option — AZ, CA, FL, NV, TX only — priced well above the roster median at $215/mo semaglutide and $320/mo tirzepatide, with nothing addressing PCOS or postpartum timing. Its own copy requires a telehealth Good Faith Exam before any prescription and states plainly that these are compounded, not FDA-approved, medications — a disclosure worth reading before you compare it to a brand-name price.

Semaglutide:

$215/mo

Tirzepatide:

$320/mo

States:

AZ, CA, FL, NV, TX only — the narrowest footprint checked this round

A tirzepatide-only (no semaglutide) provider with an all-inclusive, 4-week-cycle dose ladder starting at $224 and now offering a needle-free oral dissolvable tablet option — cash-pay, with no state list or named pharmacy published.

Semaglutide:

Not offered

Tirzepatide:

$224/4wks starting

States:

Not disclosed — no published state list

Two prices for the same vial are live on this site right now. The homepage comparison table says compounded semaglutide is $129 a month; the product page, the cart and the product page's own title tag say $199, and add that a $25 monthly membership is required to buy at all. The vial itself is a genuinely good structure — a full four-week supply at one flat price from 0.25 mg up to 2.5 mg, with refills you request rather than get charged for. It is the price tag that cannot make up its mind.

Semaglutide:

$224/mo all-in

Tirzepatide:

$324/mo all-in

States:

Not published

Two businesses are described on this one site. The homepage sells a flat program — "as low as $225 per month, which includes telemedicine visits, nutrition and exercise coaching, and medication." The FAQ says it accepts most major insurance, that your cost depends on your plan, and explains how to fax your insurance details in. Nothing reconciles them. The same page also carries two different Miami addresses and two different support addresses.

Semaglutide:

From $225/mo including medication, plus a $50 consultation

Tirzepatide:

Not priced separately

States:

Not published

Now operating as Try Invigor after invigormedical.com's domain redirect, this one prices its two mechanism-based tiers — GLP-1 from $225/mo, GLP-1+GIP from $350/mo — without ever naming semaglutide or tirzepatide directly, or disclosing compounded-vs-brand status. It claims licensing in all 50 states with no exclusions list, and uses a phone consultation rather than live video.

Semaglutide:

From $225/mo

Tirzepatide:

From $350/mo

States:

"50 States Licensed" per its own site; no state-by-state list published

A no-membership-fee compounded program with a real commitment-length discount ladder — $225/mo semaglutide or $265/mo tirzepatide with no commitment, down to $95-145/mo on a 12-month plan — verified by pulling its React app's compiled bundle since the raw page renders empty.

Semaglutide:

$225/mo

Tirzepatide:

$265/mo

States:

All 50 states + DC

Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own warning letter on 09/09/2025 for making false or misleading claims about these exact products, a regulatory finding we confirmed directly on FDA.gov and one the site itself never mentions.

Semaglutide:

$225/mo

Tirzepatide:

$299/mo

States:

All states except Alabama

Two things shape this listing more than the price does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already among the higher compounded rates here before that adjustment. What is on the credit side is real: a longevity platform with eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states.

Semaglutide:

$229 per 4 weeks

Tirzepatide:

$299 per 4 weeks

States:

All 50 states claimed, with exceptions in the terms

One of the most transparently priced compounded shops in this batch — $230/mo semaglutide or $330/mo tirzepatide month-to-month, down to $120/mo and $170/mo on the annual plan, with an explicit no-membership-fee guarantee, though no postpartum or PCOS-specific content.

Semaglutide:

$230/mo standard

Tirzepatide:

$330/mo standard

States:

All 50 states

A real, named 27-state list instead of a vague nationwide claim — $247/mo semaglutide, $296-396/mo tirzepatide depending on the dose tier — but it's a general longevity/performance-medicine platform with nothing addressing PCOS or postpartum metabolic changes, and its FAQ and Terms pages both 404'd.

Semaglutide:

$247/mo

Tirzepatide:

$296/mo

States:

27 states

Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting.

Semaglutide:

$249/mo

Tirzepatide:

$297/mo

States:

Not published

A flat-fee solo-provider program — $249/mo semaglutide, $379/mo tirzepatide, Quest labs included, with an explicit 'no increases as you continue' promise — but coverage is limited to 20 named states and no content addresses postpartum or PCOS.

Semaglutide:

$249/mo, flat

Tirzepatide:

$379/mo, flat

States:

20 states (AZ, CO, CT, FL, ID, IA, KS, MD, MA, MI, NE, NH, NM, NY, OR, UT, VT, WA, WI, WY)

A straightforward three-plan menu — semaglutide, tirzepatide, and a needle-free oral option — priced all-inclusive with no hidden membership fee, but with none of the pregnancy, breastfeeding, or named-clinician disclosure some mothers will want.

Semaglutide:

$249/mo

Tirzepatide:

$339/mo

States:

All 50 states + D.C. (self-reported; some services may vary)

A flat $249/mo semaglutide and $339/mo tirzepatide program with a genuine oral tablet option at $279/mo, all-inclusive of consult, oversight, and shipping by its own account — and a previously-flagged price inconsistency that resolves cleanly on today's own pricing page.

Semaglutide:

$249/mo

Tirzepatide:

$339/mo

States:

All 50 states (as advertised)

Compounded semaglutide at $249 a month and tirzepatide at $349, both flat at every dose and both genuinely month-to-month. Every cheaper number on the site is a prepaid block rather than a rate: the advertised 'as low as $159' is $477 charged once for three months, shipped together, and restricted to first-time patients in selected states. Zappy also arranges brand Wegovy and Zepbound as a $99 care plan with the medication billed separately, which is a different kind of purchase entirely. It received an FDA warning letter in February 2026 and has since removed the claims that were cited.

Semaglutide:

$249/mo month-to-month

Tirzepatide:

$349/mo month-to-month

States:

49 states — not available in Hawaii

Both molecules priced identically under the same tiered structure — $249/mo standard, dropping to $199/mo on a 3-month plan or $165/mo on a 6-month plan — nationwide, with a $179 first-month promotional rate.

Semaglutide:

$249/mo standard

Tirzepatide:

$249/mo standard

States:

All 50 states

Rare for showing compounded AND brand-name pricing on the same page — semaglutide from $149/mo, tirzepatide from $249/mo on 3-month plans, flat $1,499/mo brand options — but nothing addresses PCOS or postpartum metabolic changes, and its own FAQ quotes a stale price the live checkout has already undercut.

Semaglutide:

$249/mo month-to-month ($149/mo on the 3-month plan)

Tirzepatide:

$349/mo month-to-month ($249/mo on the 3-month plan)

States:

Not disclosed — no published state list

A dose-tiered compounded program ($249-$349/mo semaglutide, $349-$649/mo tirzepatide) that names its fulfilling pharmacy up front, but pairs that transparency with an unusually harsh policy — no changes, no cancellations, and no returns once you submit.

Semaglutide:

$249/mo

Tirzepatide:

$349/mo

States:

Does not disclose a specific state list

Credit where it is due: KERNX prints both numbers side by side, which most sellers do not. The card reads "From $129/mo · $249/mo after founding period" for semaglutide and "From $199/mo · $299/mo" for tirzepatide, so the introductory rate and the one you will actually settle on are visible in the same glance. What that honesty reveals is a steep climb — 93% on semaglutide and 50% on tirzepatide — and there is a second cost that sits outside both figures entirely: "consultation fees range from $25 to $60", charged separately. Budget $249 plus a consult fee, not $129, and the decision looks different.

Semaglutide:

$249/mo once the founding period ends

Tirzepatide:

$299/mo once the founding period ends

States:

Not stated on the site

Every price Fridays advertises — $117, $150, $198, $240 — is a prepaid annual rate. The site says so in small type beside each one: "Paid annually, delivered monthly." If you want to pay by the month, the same compounded semaglutide is $249 and the tirzepatide is $359, both printed on the same page. That is the number to plan around, because a twelve-month prepay is a different financial decision from a subscription you can stop. To Fridays' credit, it names its operator, address and phone in the footer, which most sellers do not.

Semaglutide:

$249/mo on the month-to-month plan

Tirzepatide:

$359/mo on the month-to-month plan

States:

Not published on the site

Everything about the price is public and nothing about the company is. AHBARx publishes six figures before you enter anything: compounded semaglutide at $249 a month, $649 for three months and $1,199 for six, and tirzepatide at $349, $949 and $1,799, which works out to about $200 and $300 a month on the longest plan. The advertised savings are exact to the dollar against its own monthly rate, which is rarer than it should be. The problem sits in the legal documents. No operating entity is named anywhere on the public site, and the terms and privacy policy are an unfilled template in which the compounding pharmacies, the laboratories and the medical groups are all literal bracketed placeholders — as is the site's own web address. It sells NAD+, sermorelin and glutathione alongside the GLP-1s, claims all fifty states without listing them, and says nothing about pregnancy, breastfeeding or postpartum timing.

Semaglutide:

$249/mo

Tirzepatide:

$349/mo

States:

All 50 states, claimed but not enumerated

There are two entirely different ways to buy here and they are priced on different units, which is where this gets confusing. The cheaper-looking numbers — $199, $299, $399 — are not months. They are dose-capped vials: "Up To 1 mg", "Up To 2.5 mg", "Up To 5mg", "Up To 10mg", each with a $45 one-time appointment fee and $19 shipping on top. The monthly subscription is the other column, at $249 for semaglutide and $349 for tirzepatide, and that one does include the provider, the medication and free shipping.

Semaglutide:

$249/mo on the subscription plan

Tirzepatide:

$349/mo on the subscription plan

States:

Not published on the site

Compounded semaglutide + B12 and tirzepatide + B12, with a true standing rate of $249.97/mo and $349.97/mo once the first-month promo ends — an app whose pricing appears only once its scripts run, on a page that never names its medical group or pharmacy and whose own ad-tracking treats a 12-month prepay rate as the real price.

Semaglutide:

$249.97/mo

Tirzepatide:

$349.97/mo

States:

Not disclosed — no published exclusion list found; a full 50-state selector appears at intake

There is a real clinic behind this one — an address in Oakland, Maine, a phone number, free consultations every Wednesday afternoon. And there is a line on its pricing page that nothing else on this roster comes close to: "Add Retatrutide to your current Semaglutide or Tirzepatide regimen for just $100/month." Retatrutide has no FDA approval for anything. It is still in phase 3 trials. There is no labeled dose, no labeled safety profile, and nothing at all about stacking it on top of a drug you are already taking.

Semaglutide:

$250/mo

Tirzepatide:

$325/mo

States:

A Central Maine clinic; no wider coverage published

AurenRx names both the practice that prescribes and the pharmacy that compounds, with addresses — Wasef Health, PC c/o Michael Wasef MD in Pinellas Park, Florida, and VialsRX in Houston, Texas — and the prescriber's details match the federal NPI registry exactly. It charges the same for either molecule, which is genuinely unusual: $259 a month on a recurring plan or $299 with no commitment, for semaglutide or tirzepatide alike, plus a low-and-slow microdose track at $229/$250. Everything is included in that price, the online visit is free, and the LegitScript badge it displays is real. The problem is its own front page. AurenRx advertises its GLP-1 and Microdose programs at 'from $129/mo' on the homepage, while the cheapest thing you can actually buy on the product page is $229 — nothing costs $129. That is not a promotion that expired or a plan you have to hunt for; it is roughly half the real price, sitting on the page most readers see first.

Semaglutide:

$259/mo

Tirzepatide:

$259/mo

States:

All 50 states